{"id":558704,"date":"2026-06-12T02:00:00","date_gmt":"2026-06-12T00:00:00","guid":{"rendered":"https:\/\/medizinonline.com\/innovative-treatment-approaches-for-pbc-psc-and-aih-whats-new\/"},"modified":"2026-06-17T11:00:06","modified_gmt":"2026-06-17T09:00:06","slug":"innovative-treatment-approaches-for-pbc-psc-and-aih-whats-new","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/en\/innovative-treatment-approaches-for-pbc-psc-and-aih-whats-new\/","title":{"rendered":"Innovative Treatment Approaches for PBC, PSC, and AIH: What&#8217;s New?"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>PPAR agonists as second-line therapy have proven effective in primary biliary cholangitis (PBC) not only in clinical trials but also in real-world settings, as recent research findings show. In primary sclerosing cholangitis (PSC), norucholic acid (NCA) improved relevant laboratory values and demonstrated hepatoprotective effects. Regarding autoimmune hepatitis (AIH), a recent analysis evaluated how mycophenolate mofetil compares to azathioprine, each in combination with prednisolone.  <\/strong><\/p>\n\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/en\/my-account\/packages\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/en\/log-in\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fen%2Finnovative-treatment-approaches-for-pbc-psc-and-aih-whats-new%2F\">Log in here<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>PPAR agonists as second-line therapy have proven effective in primary biliary cholangitis (PBC) not only in clinical trials but also in real-world settings, as recent research findings show. In primary&#8230;&hellip;... <\/p>\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/en\/my-account\/packages\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/en\/log-in\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fen%2Finnovative-treatment-approaches-for-pbc-psc-and-aih-whats-new%2F\">Log in here<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":558707,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Autoimmune Liver Diseases  ","footnotes":"[{\"content\":\"<em>POISE response criteria = ALP [alkaline phosphatase] <1.67\\u00d7 ULN, as well as a 15% reduction in ALP and normal total bilirubin levels after 1 year.  <\\\/em>\",\"id\":\"4b3154c2-2e71-44d9-b2fc-5c3e68c86fac\"},{\"content\":\"<em>ULN (upper limit of normal) = upper limit of the normal range<\\\/em>\",\"id\":\"85539fe2-6d0e-4c82-9a2e-85cb9bf78fe2\"}]"},"category":[11548,11513,11391,11297,11503],"tags":[72841,63809,72844,14227,94699,94698,32456,94697,27670,32452,32462,32470,11938],"powerkit_post_featured":[],"class_list":["post-558704","post","type-post","status-publish","format-standard","has-post-thumbnail","category-rx-en","category-congress-reports","category-gastroenterology-and-hepatology","category-general-internal-medicine","category-studies","tag-aih-en","tag-autoimmune-hepatitis","tag-autoimmune-liver-diseases","tag-azathioprine","tag-nca","tag-norucholic-acid","tag-pbc-en","tag-ppar-agonists","tag-prednisolone","tag-primary-biliary-cholangitis","tag-primary-sclerosing-cholangitis","tag-psc-en","tag-second-line-therapy","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-06-26 23:58:56","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"en_US","wpml_translations":{"fr_FR":{"locale":"fr_FR","id":558430,"slug":"approches-therapeutiques-davenir-pour-la-cbp-la-csp-et-lhai-quelles-sont-les-dernieres-avancees","post_title":"Approches th\u00e9rapeutiques d'avenir pour la CBP, la CSP et l'HAI : quelles sont les derni\u00e8res avanc\u00e9es ?","href":"https:\/\/medizinonline.com\/fr\/approches-therapeutiques-davenir-pour-la-cbp-la-csp-et-lhai-quelles-sont-les-dernieres-avancees\/"},"it_IT":{"locale":"it_IT","id":558716,"slug":"approcci-terapeutici-allavanguardia-per-la-pbc-la-psc-e-laih-quali-sono-le-novita","post_title":"Approcci terapeutici all\u2019avanguardia per la PBC, la PSC e l\u2019AIH: quali sono le novit\u00e0?","href":"https:\/\/medizinonline.com\/it\/approcci-terapeutici-allavanguardia-per-la-pbc-la-psc-e-laih-quali-sono-le-novita\/"},"pt_PT":{"locale":"pt_PT","id":558740,"slug":"abordagens-terapeuticas-inovadoras-para-a-pbc-a-psc-e-a-aih-quais-sao-as-novidades","post_title":"Abordagens terap\u00eauticas inovadoras para a PBC, a PSC e a AIH: Quais s\u00e3o as novidades?","href":"https:\/\/medizinonline.com\/pt-pt\/abordagens-terapeuticas-inovadoras-para-a-pbc-a-psc-e-a-aih-quais-sao-as-novidades\/"},"es_ES":{"locale":"es_ES","id":558746,"slug":"enfoques-terapeuticos-innovadores-para-la-cbp-la-csp-y-la-hai-que-novedades-hay","post_title":"Enfoques terap\u00e9uticos innovadores para la CBP, la CSP y la HAI: \u00bfqu\u00e9 novedades hay?","href":"https:\/\/medizinonline.com\/es\/enfoques-terapeuticos-innovadores-para-la-cbp-la-csp-y-la-hai-que-novedades-hay\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts\/558704","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/comments?post=558704"}],"version-history":[{"count":1,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts\/558704\/revisions"}],"predecessor-version":[{"id":558709,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts\/558704\/revisions\/558709"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/media\/558707"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/media?parent=558704"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/category?post=558704"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/tags?post=558704"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/powerkit_post_featured?post=558704"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}